
0:43
A clinician (Dr. Charles Mok) describes using platelet-rich plasma (PRP) or platelet-rich fibrin (PRF), sometimes combined with cross-linked hyaluronic material, as a three-treatment series to reduce arthritis-related joint pain. The speaker reports that roughly 80% of patients experience >50% pain reduction lasting about nine months to 1.5 years, and that the approach appears to work across mild to severe arthritis (including bone-on-bone), offering an alternative to pain pills, steroid injections, or knee replacement.










